Jason Kelce is having a fun retirement — and seemingly turning heads while hanging with fans. The longtime Eagles center was spotted relaxing shirtless on a beach — geotagged in New Jersey ...

Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

We recently compiled a list of the 8 Best US Stocks For Foreign Investors Right Now. In this article, we are going to take a ...

Viad Corp, a public company, has entered into a definitive agreement with private Los Angeles-based private equity firm ...

Sept 25 (Reuters) - Merck (MRK.N), opens new tab said on Wednesday a combination of its experimental drug and blockbuster therapy Keytruda failed a late-stage trial testing it in previously ...

Jason Zweig writes The Intelligent Investor column every weekend for The Wall Street Journal. He also writes Back in Business, an occasional column about financial history. Jason is the author of ...

Oppenheimer Asset Management highlights eight stocks in Health Care and Consumer Staples sectors poised for short positions amid S&P 500 highs.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Jason Zemansky’s rating is based on a nuanced analysis of ... Market dominance by competitors like Merck and recent clinical disappointments have raised questions about dom’s potential to be a profit ...

Strategists Jason DeSena Trennert and Ryan Grabinski, of the institutional brokerage Strategas, point out that 117 of the S ...

We recently compiled a list of the 10 Best Fortune 500 Stocks To Buy Now. In this article, we are going to take a look at where ServiceNow Inc. (NOW) stands against the other Fortune 500 stocks.

SEATTLE, Oct. 04, 2024 (GLOBE NEWSWIRE) -- (OTC Pink: KANT) , a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune ...